logo

For the Inventor, By the Inventor

Franklin, TN, United States of America

Raymond Mernaugh

This inventor holds 14 USPTO granted patents and 1 published patent application, primarily in Immunological Sensors. Top assignees: Vanderbilt University, Oakland University, Other. Active years: 2007-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raymond Mernaugh. Retrieved from https://idiyas.com/inventor/raymond-mernaugh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 42.9

Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Nashville, TN (US) (2007 - 2011)
  • St. Louis, MO (US) (2013)
  • Franklin, TN (US) (2008 - 2018)

Company Filing History:

goldMedal13 out of 1,228 
 
Vanderbilt University
 patents
silverMedal3 out of 38 
 
Oakland University
 patents
bronzeMedal1 out of 834,708 
Other
 patents
where one patent can have more than one assignee

Years Active: 2007-2018

Loading Chart...
Areas of Expertise:
Target Analyte Detection
Cancer Therapeutics
Phage Antibodies
Immunological Compositions
Porous Membrane Sensors
Waveguide Sensors
Immunosensors
scFv-Linker Design
Endothelial Cell Regulation
Angiogenesis Modulation
Biological Targets
Chemical Targets
14 patents (USPTO):Explore Patents
1. 10082500 - Device and method for detecting a target analyte (2018-09-25),
2. 9745377 - Immunological compositions as cancer therapeutics (2017-08-29),
3. 9023362 - Immunological compositions as cancer therapeutics (2015-05-05),
4. 8927288 - Phage antibodies to radiation-inducible neoantigens (2015-01-06),
5. 8920729 - Porous membrane waveguide sensors and sensing systems therefrom for detecting biological or chemical targets (2014-12-30),
6. 8617521 - Phage antibodies to radiation-inducible neoantigens (2013-12-31),
7. 8506887 - Porous membrane waveguide sensors and sensing systems therefrom for detecting biological or chemical targets (2013-08-13),
8. 8486413 - Immunological compositions as cancer therapeutics (2013-07-16),
9. 8148170 - Immunosensors: scFv-linker design for surface immobilization (2012-04-03),
10. 8012945 - Phage antibodies to radiation-inducible neoantigens (2011-09-06),
11. 7888134 - Immunosensors: scFv-linker design for surface immobilization (2011-02-15),
12. 7329536 - Piezoimmunosensor (2008-02-12),
13. 7306925 - Phage antibodies to radiation-inducible neoantigens (2007-12-11),
14. 7176289 - Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis (2007-02-13),

Title: Inventor Raymond Mernaugh: Pioneering Innovations in Franklin, TN

Introduction: Raymond Mernaugh is a distinguished inventor based in Franklin, TN, known for his groundbreaking contributions to various industries.

Latest Patents: Raymond Mernaugh holds several patents in the fields of technology, healthcare, and consumer products, showcasing his versatility and ingenuity.

Career Highlights: Throughout his career, Raymond Mernaugh has demonstrated a keen ability to identify gaps in the market and develop innovative solutions to address them. His inventions have not only improved efficiency but have also enhanced the quality of life for many individuals.

Collaborations: Raymond Mernaugh has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His partnerships have been instrumental in turning his ideas into tangible products that have made a significant impact on society.

Conclusion: Inventor Raymond Mernaugh's relentless pursuit of innovation and his passion for creating solutions to real-world problems have solidified his reputation as a visionary in the field of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…